Ana Martins

4.1k total citations
80 papers, 2.4k citations indexed

About

Ana Martins is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Ana Martins has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 25 papers in Molecular Medicine and 16 papers in Pharmacology. Recurrent topics in Ana Martins's work include Antibiotic Resistance in Bacteria (25 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). Ana Martins is often cited by papers focused on Antibiotic Resistance in Bacteria (25 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). Ana Martins collaborates with scholars based in Portugal, Hungary and France. Ana Martins's co-authors include Leonard Amaral, Miguel Viveiros, Joséph Molnár, Attila Hunyadi, Gabriella Spengler, Marta Martins, Isabel Couto, István Zupkó, Lı́gia Salgueiro and Liliana Rodrigues and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Ana Martins

79 papers receiving 2.3k citations

Peers

Ana Martins
Ana Martins
Citations per year, relative to Ana Martins Ana Martins (= 1×) peers Sumiko Shiota

Countries citing papers authored by Ana Martins

Since Specialization
Citations

This map shows the geographic impact of Ana Martins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martins more than expected).

Fields of papers citing papers by Ana Martins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Martins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martins. The network helps show where Ana Martins may publish in the future.

Co-authorship network of co-authors of Ana Martins

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Martins. A scholar is included among the top collaborators of Ana Martins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Martins. Ana Martins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbosa, Regina María, Ana Martins, Ivo Oliveira, et al.. (2025). Anti-inflammatory and Antioxidant Properties of Almond-Skin Acetonic Extract in Zebrafish (Danio rerio) Copper-Sulphate-induced Inflammation. Planta Medica. 91(14). 850–861.
3.
Latorre, Andréia Oliveira, et al.. (2019). Non-relevance of acute dermal toxicity testing for assessing human health protection in the regulatory decision-making for agrochemical formulated products. Regulatory Toxicology and Pharmacology. 106. 105–110. 4 indexed citations
4.
Martins, Ana, István Zupkó, Tamás Gáti, et al.. (2017). Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam. European Journal of Medicinal Chemistry. 144. 730–739. 29 indexed citations
5.
Béni, Zoltán, Miklós Dékány, Csaba Szántay, et al.. (2016). Biomimetic synthesis and HPLC–ECD analysis of the isomers of dracocephins A and B. Beilstein Journal of Organic Chemistry. 12. 2523–2534. 11 indexed citations
6.
Stanković, Tijana, Ana Martins, Aleksandra Isaković, et al.. (2015). Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives. Cancer Chemotherapy and Pharmacology. 76(3). 555–565. 17 indexed citations
7.
Jones‐Dias, Daniela, Vera Manageiro, Ana Martins, Eugénia Ferreira, & Manuela Caniça. (2015). New Class 2 Integron In 2-4 Among IncI1-Positive Escherichia coli Isolates Carrying ESBL and PMAβ Genes from Food Animals in Portugal. Foodborne Pathogens and Disease. 13(1). 36–39. 14 indexed citations
8.
Hajdú, Zsuzsanna, Ana Martins, Orsolya Orbán-Gyapai, et al.. (2014). Xanthine Oxidase-Inhibitory Activity and Antioxidant Properties of the Methanol Extract and Flavonoids of Artemisia Asiatica. Records of Natural Products. 8(3). 299–302. 23 indexed citations
9.
Amaral, Leonard, Ana Martins, Gabriella Spengler, & Joséph Molnár. (2014). Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them. Frontiers in Pharmacology. 4. 168–168. 121 indexed citations
10.
Duarte, Andreia, Andrea Santos, Vera Manageiro, et al.. (2014). Human, food and animal Campylobacter spp. isolated in Portugal: High genetic diversity and antibiotic resistance rates. International Journal of Antimicrobial Agents. 44(4). 306–313. 57 indexed citations
11.
Martins, Ana, Attila Hunyadi, & Leonard Amaral. (2013). Mechanisms of Resistance in Bacteria: An Evolutionary Approach. The Open Microbiology Journal. 7(1). 53–58. 24 indexed citations
12.
Hunyadi, Attila, Ana Martins, Tusty‐Jiuan Hsieh, Adrienn B. Seres, & István Zupkó. (2012). Chlorogenic Acid and Rutin Play a Major Role in the In Vivo Anti-Diabetic Activity of Morus alba Leaf Extract on Type II Diabetic Rats. PLoS ONE. 7(11). e50619–e50619. 191 indexed citations
13.
Martins, Ana, et al.. (2011). Role of calcium in the efflux system of Escherichia coli. International Journal of Antimicrobial Agents. 37(5). 410–414. 40 indexed citations
14.
Spengler, Gabriella, Liliana Rodrigues, Ana Martins, et al.. (2011). Genetic response of Salmonella enterica serotype Enteritidis to thioridazine rendering the organism resistant to the agent. International Journal of Antimicrobial Agents. 39(1). 16–21. 20 indexed citations
15.
Pascu, Mihail–Lucian, Viorel Nastasa, Adriana Smarandache, et al.. (2011). Direct Modification of Bioactive Phenothiazines by Exposure to Laser Radiation. Recent Patents on Anti-Infective Drug Discovery. 6(2). 147–157. 19 indexed citations
16.
Martins, Ana, Andrea Vasas, Zsuzsanna Schelz, et al.. (2010). Constituents of Carpobrotus edulis inhibit P-glycoprotein of MDR1-transfected mouse lymphoma cells.. PubMed. 30(3). 829–35. 44 indexed citations
17.
Spengler, Gabriella, Miguel Viveiros, Marta Martins, et al.. (2009). Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method.. PubMed. 29(6). 2173–7. 20 indexed citations
18.
Martins, Ana, Carol Iversen, Liliana Rodrigues, et al.. (2009). An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators. International Journal of Antimicrobial Agents. 34(6). 602–604. 21 indexed citations
19.
Amaral, Leonard, Gabriella Spengler, Miguel Viveiros, et al.. (2008). Assessment and comparison of efflux pumps of cancer cells and MDR bacteria under physiological conditions by a real-time semi-automated system. Anticancer Research. 28. 3193–3194. 1 indexed citations
20.
Viveiros, Miguel, Ana Martins, Laura Paixão, et al.. (2008). Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. International Journal of Antimicrobial Agents. 31(5). 458–462. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026